Del(5Q)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD (NCT05924100) | Associazione Qol-one | 2022-11-03 |
Track Del(5Q) automatically
Every clearance here is in the API, with alerts when new ones post.